Future studies expanded these findings, demonstrating sustained increases in serum IL-2, IL-6, IL-10, and IFN-γ in severe COVID-19 cases, with higher IL-6 levels correlating with mortality risk. The gene discussed is IFNG; the disease is COVID-19.